The influence of co-morbidities on annualised bleeding rates in patients with severe haemophilia A: experiences from the pivotal turoctocog alfa prophylaxis trial (guardianTM1)

JOURNAL OF THROMBOSIS AND HAEMOSTASIS(2013)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要